SCHEMBL8280928

SCHEMBL8280928

CCOc1ccc(-c2nnc(C)n2-c2ccc3c(c2)OCC3)cc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 8/20 0.58
AVPR1A P37288 7/20 0.45
AVPR2 P30518 2/20 0.43
GRM2 Q14416 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
S1PR1 P21453 1/20 0.35
MAPK1 P28482 1/20 0.35
OGA O60502 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
METAP2 P50579 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8281723 0.92 OXTR (0.58) OXTRAVPR1AAVPR2GRM2KDM4E
SCHEMBL8282113 0.79 OXTR (0.71) OXTRAVPR1AAVPR2KDM4ENPSR1
SCHEMBL8279809 0.77 OXTR (0.68) OXTRAVPR1AAVPR2NPSR1MAPT
SCHEMBL8281669 0.76 OXTR (0.77) OXTRAVPR1AAVPR2GRM2HPGD
SCHEMBL8282111 0.74 OXTR (0.61) OXTRAVPR1AAVPR2KDM4ENPSR1
SCHEMBL8282112 0.73 OXTR (1.00) OXTRAVPR1AAVPR2
SCHEMBL12208496 0.64 NQO1 (0.43) NPSR1ALDH1A1HPGDSMN1; SMN2
SCHEMBL6511017 0.63 OXTR (0.80) OXTRAVPR1AAVPR2
SCHEMBL8282084 0.62 OXTR (0.81) OXTRAVPR1AAVPR2MEN1KMT2A
SCHEMBL5001008 0.61 CACNA2D1 (0.64) KDM4ENPSR1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005082866-A2 SUBSTITUTED 1, 2, 4- TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS PFIZER LIMITED (GB) 2005-09-09 WO disclosed